MYC and hematologic disorder: In hematological malignancies c-MYC regulation is lost and often occurs when it is aberrantly expressed via amplification or genetic alteration, consequently leading to events ranging from promotion of excessive proliferation of altered cells to inhibition of apoptosis 8,15,16.